Renal Impairment Evaluation
Renal Impairment Evaluation - Related Videos
01:17
Factors Affecting Renal Clearance: Renal Impairment
0 Views •
2025
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body. One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
02:39
Evaluating Motor Impairment in C. elegans Models Using the Radial Locomotion Assay
0 Views •
2025
This video demonstrates the use of a radial locomotion assay to evaluate motor dysfunction in C. elegans expressing either wild-type or ALS-mutant human TDP-43 protein. Worms with varying levels of wild-type or mutant TDP-43 expression are allowed to crawl, and their movement is measured by the radial distance traveled from the central point on the assay plate. The assay distinguishes between mild, moderate, and severe motor impairments based on the distance traveled by the different C. elegans...
08:34
Thinking Too Much Impairs Decision-Making
0 Views •
2023
Source: Peter Mende-Siedlecki & Jay Van Bavel—New York University When we are considering a tough choice between two or more attractive options, we often end up actively weighing the pros and cons of each alternative. By reflecting on their advantages and disadvantages, we attempt to fit a complex, subjective decision into an orderly set of criteria. However, research in psychology suggests that this sort of introspective approach might not always yield the most optimal outcomes.1 In other...
08:38
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
0 Views •
Cited by 13 •
2013
We describe the manufacture of compressed hormone pellets, as well as subcutaneous surgical implantation into mice. This strategy can be combined with the growth of cell and tissue xenografts under the renal capsule of athymic nude mice to evaluate hormonal carcinogenesis and regulation of benign prostate growth.
07:18
Transcutaneous Assessment of Renal Function in Conscious Rodents
0 Views •
Cited by 34 •
2016
Determination of glomerular filtration rate (GFR) is the gold standard to assess overall kidney function. However, traditional procedures to measure this parameter are cumbersome and require a large investment of time. Here we describe a faster and minimally invasive method to determinate GFR transcutaneously.
FAQs
Serum creatinine and estimated glomerular filtration rate (eGFR) contribute different but related views of kidney function. Creatinine supplies a measured serum result, while eGFR expresses filtration as an estimate. Considering them together helps clinicians evaluate reduced filtration, interpret severity, and follow change over time rather than relying on one laboratory value alone.
Repeated results help determine whether an abnormal finding is persistent or temporary. This distinction matters because a single change may not represent progressive renal disease, whereas ongoing abnormalities can support continued evaluation and monitoring. Comparing results over time strengthens clinical interpretation, helps assess progression, and informs whether additional investigation, referral, or treatment decisions should be considered.
Urine albumin or protein testing adds information that serum measurements alone may not provide, while electrolyte assessment can reveal associated abnormalities. Medical history and physical findings supply clinical context for interpreting laboratory results. Together, these elements help clinicians evaluate both functional change and evidence of kidney injury, improving assessment of disease pattern and clinical significance.
A practical evaluation begins with clinical history and physical findings, followed by serum creatinine, estimated glomerular filtration rate, urine albumin or protein testing, and electrolyte assessment. Clinicians then interpret the results together, repeat testing when needed, and use the overall pattern to decide on monitoring, treatment, referral, imaging, or specialized investigation. The sequence may be adapted to the clinical situation.
Renal impairment evaluation supports different clinical questions in acute and chronic disease. Repeated findings help identify persistent impairment and progressive renal disease, while the broader assessment can detect reduced filtration or urinary abnormalities requiring attention. The results also support chronic kidney disease staging and acute kidney injury detection, although interpretation depends on the complete clinical picture rather than one test.
Clinicians apply the results beyond diagnosis. Findings can guide medication dose adjustment, estimate cardiovascular and renal risk, and determine the intensity of monitoring. They may also support treatment choices or prompt referral, imaging, or specialized investigation when the pattern warrants it. In this way, evaluation connects laboratory and clinical findings with practical decisions about ongoing care.